These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34167889)

  • 1. A comparison of insulin doses for treatment of hyperkalaemia in intensive care unit patients with renal insufficiency.
    Verdier M; DeMott JM; Peksa GD
    Aust Crit Care; 2022 May; 35(3):258-263. PubMed ID: 34167889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comparison of Insulin Doses for the Treatment of Hyperkalemia in Patients with Renal Insufficiency.
    LaRue HA; Peksa GD; Shah SC
    Pharmacotherapy; 2017 Dec; 37(12):1516-1522. PubMed ID: 28976587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood glucose reduction in patients treated with insulin and dextrose for hyperkalaemia.
    Aljabri A; Perona S; Alshibani M; Khobrani M; Jarrell D; Patanwala AE
    Emerg Med J; 2020 Jan; 37(1):31-35. PubMed ID: 31653693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5 versus 10 Units of Intravenous Insulin for Hyperkalemia in Patients With Moderate Renal Dysfunction.
    Finder SN; McLaughlin LB; Dillon RC
    J Emerg Med; 2022 Mar; 62(3):298-305. PubMed ID: 35058093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches.
    Ngugi NN; McLigeyo SO; Kayima JK
    East Afr Med J; 1997 Aug; 74(8):503-9. PubMed ID: 9487416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of standard- vs reduced-dose insulin for treatment of hyperkalemia: A quasi-experiment.
    Pearson SC; O'Connor K; Keller K; Hodge TJ; Nesbit R
    Am J Health Syst Pharm; 2022 Feb; 79(Suppl 1):S13-S20. PubMed ID: 34597356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iatrogenic hypoglycaemia following glucose-insulin infusions for the treatment of hyperkalaemia.
    Tee SA; Devine K; Potts A; Javaid U; Razvi S; Quinton R; Roberts G; Leech NJ
    Clin Endocrinol (Oxf); 2021 Feb; 94(2):176-182. PubMed ID: 32979855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Insulin Dosing Strategies for Hyperkalemia Management at an Academic Medical Center.
    Cook ME; Tran LK; DeGrado JR; Alkazemi A; Marino KK
    Clin Ther; 2024 May; 46(5):382-388. PubMed ID: 38594106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes associated with the emergency treatment of hyperkalaemia with intravenous insulin-dextrose.
    Humphrey TJL; James G; Wilkinson IB; Hiemstra TF
    Eur J Intern Med; 2022 Jan; 95():87-92. PubMed ID: 34625340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing the harm associated in treating hyperkalaemia with insulin and dextrose.
    Abou Sherif S; Katsaiti I; Jebb H; Banh S; Bedi R; Levy J; Thomas D; Ashby D; Corbett R
    Clin Med (Lond); 2024 Jul; 24(4):100222. PubMed ID: 38871123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoglycemia following intravenous insulin plus glucose for hyperkalemia in patients with impaired renal function.
    Coca A; Valencia AL; Bustamante J; Mendiluce A; Floege J
    PLoS One; 2017; 12(2):e0172961. PubMed ID: 28245289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoglycaemia due to insulin therapy for the management of hyperkalaemia in hospitalised adults: A scoping review.
    Chothia MY; Humphrey T; Schoonees A; Chikte UME; Davids MR
    PLoS One; 2022; 17(5):e0268395. PubMed ID: 35552566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreasing Hypoglycemia following Insulin Administration for Inpatient Hyperkalemia.
    Tran AV; Rushakoff RJ; Prasad P; Murray SG; Monash B; Macmaster H
    J Hosp Med; 2020 Feb; 15(2):368-370. PubMed ID: 32039749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a Hyperkalemia Protocol Tailored to Glucose Concentration and Renal Function on Insulin-Induced Hypoglycemia in Patients with Low Pretreatment Glucose.
    Dybdahl D; Roberson T; Rasor E; Kline L; Pershing M
    J Emerg Med; 2024 Apr; 66(4):e421-e431. PubMed ID: 38462394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoglycaemia following treatment of hyperkalaemia with insulin and dextrose.
    Williams PS; Davenport A; Bone JM
    Postgrad Med J; 1988 Jan; 64(747):30-2. PubMed ID: 3047719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience using high-dose glucose-insulin-potassium (GIK) in critically ill patients.
    Slob EMA; Shulman R; Singer M
    J Crit Care; 2017 Oct; 41():72-77. PubMed ID: 28500918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors, prevention and treatment of hypoglycaemia after hyperkalaemia in adult patients using intravenous insulin: An integrative review.
    Long DS; Kelly MA; Lim SH
    Int J Nurs Pract; 2023 Feb; 29(1):e13080. PubMed ID: 35859317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of Hypoglycemia in Patients With Low eGFR Treated With Insulin and Dextrose for Hyperkalemia.
    Pierce DA; Russell G; Pirkle JL
    Ann Pharmacother; 2015 Dec; 49(12):1322-6. PubMed ID: 26416951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe hyperkalaemia resulting from octreotide use in a haemodialysis patient.
    Adabala M; Jhaveri KD; Gitman M
    Nephrol Dial Transplant; 2010 Oct; 25(10):3439-42. PubMed ID: 20610525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemodialysis, nutritional disorders and hypoglycaemia in critical care.
    Crespo JC; Gomes VR; Barbosa RL; Padilha KG; Secoli SR
    Br J Nurs; 2017 Mar; 26(5):281-286. PubMed ID: 28328262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.